Meridian Bioscience Receives FDA Clearance for New Rapid Campylobacter Test
Meridian Bioscience Inc has announced that it has received FDA clearance for a new rapid test for Campylobacter, ImmunoCard STAT! CAMPY.
Read MoreMeridian Bioscience Inc has announced that it has received FDA clearance for a new rapid test for Campylobacter, ImmunoCard STAT! CAMPY.
Read MoreCombiMatrix Corp has announced that a validation study is available as an advance online publication in the official journal of the United States and Canadian Academy of Pathology (USCAP), Modern Pathology.
Read MoreQIAGEN has announced the official launch of its next-generation CE-labelled assay for KRAS testing in colorectal cancer patients. In addition, the company gave an update on the pipeline of its regulated assay portfolio for personalized cancer treatment based upon the Pyrosequencing technology.
Read MoreHemoCue AB, a subsidiary of Quest Diagnostics Inc, announces that it has signed an agreement with MEC Dynamics Corp (MEC) for the exclusive distribution of the Avie(TM) A1c point-of-care test in the US and Europe.
Read MoreThe LIS Testing Survey ’09 is available as a downloadable pdf – you will need Adobe Acrobat reader to view this. If you do not have Adobe Acrobat on your computer, you can download it for free from Adobe.com.
Read More